Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma - Wikidata - awgldk - TriplyDB

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

http://www.wikidata.org/entity/Q28345950

about

Paired-like homeoprotein ESXR1 acts as a sequence-specific transcriptional repressor of the human K-ras gene Targeting the RAS oncogene.Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA High-resolution three-dimensional NMR structure of the KRAS proto-oncogene promoter reveals key features of a G-quadruplex involved in transcriptional regulation.Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor.Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.EPA significantly improves anti-EGFR targeted therapy by regulating miR-378 expression in colorectal cancer

P2860

Q24302287-A0E68EB7-42A4-4C15-BE6F-B79A30745635 Q27687198-D04B1345-AFD6-4B7F-8C9F-C8FA8A936660 Q34179717-1C2B0976-3511-417F-A5B8-2F1C7C260189 Q38288597-C0155FF9-BC7C-44C8-BF1D-9BAC24BF21A9 Q38290815-CBD52292-9BBC-4ACD-88EB-53298AE22C62 Q40779601-51F66305-64EF-43FF-8C06-89D4A3A4CD01 Q51816015-F840AE0C-92BB-4DC2-B432-6A5B0666B888 Q58573219-4262AA30-1606-485C-9366-4821ACC4EC71

P2860

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

http://www.wikidata.org/entity/Q28345950

description

2001 nî lūn-bûn

@nan

2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@ast

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@en

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@nl

type

label

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@ast

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@en

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@nl

prefLabel

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@ast

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@en

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@nl

P1433

Q28345950-C30EFB7D-F31C-4A61-B806-B3E649CAC9E9

P1476

Q28345950-F02702BE-5481-40C9-A1CA-B5843B13F2F8

P2093

Q28345950-85284180-B883-4E18-961B-000D985A7B63

Q28345950-F94E638D-7F59-4FD0-82E9-F0A4399D9191

P2860

Q28345950-062AA11D-37D6-48BE-A2C9-62FF384FE1C9

Q28345950-07861BEF-8D99-48C5-A552-31140C50EDD7

Q28345950-1305F3AA-4396-4DD9-9838-D083F1769044

Q28345950-17B86B38-FF96-49B6-BC1C-B89612E6769D

Q28345950-1B176504-7EC0-4354-9554-B5DBF47FE67E

Q28345950-21E12E31-6EE2-4DD9-940C-CF7A21D5DC10

Q28345950-26831AED-9CCF-43C9-9D9E-3303DDE88F7F

Q28345950-293E37A0-40D0-4A8D-85BD-71FCF46A011E

Q28345950-29DF7EA1-0390-465D-9008-12DE4D31EC55

Q28345950-2D2F18F1-A69D-4DFB-9B9D-CCA7018B7EBE

P304

Q28345950-F746DACA-CD5E-4E6E-A41A-145D04205D90

P31

Q28345950-0AB3E2D4-A8B9-4BBC-9877-991CE9D65CD4

P356

Q28345950-E3788FC2-4D7F-4DC2-981D-750F9AC48F30

P407

Q28345950-042B3B3A-261D-415F-96C1-5184AF8866F0

P433

Q28345950-C146E7D6-3C21-439F-A742-BF79F06D5384

P478

Q28345950-9FFB9055-7322-4188-8452-07A0E3763F24

P50

Q28345950-9B2E5B9C-DC2D-4A58-87C4-ED3EA97B73D4

Q28345950-9EFD58F2-A303-4E98-B030-4A276330D8C7

P577

Q28345950-94BB7CA7-F66D-4C0C-90FF-BD27026D2CDC

P5875

Q28345950-3BF30E77-A747-4712-98DF-1DBA7129B038

P698

Q28345950-E8F17364-8E2A-4453-BB76-B45E04241B8A

P921

Q28345950-36B13DC2-4C18-478F-AAC5-D845386F3DC5

P932

Q28345950-CD5B3B0B-D45B-4813-A06E-021E18EE0C9A

P356

P1433

P1476

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

@en

P2093

H J Andreyev

http://www.w3.org/2001/XMLSchema#string

P J Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Genetic alterations during colorectal-tumor development

Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology

Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus

Ovarian expression of cellular Ki-ras p21 varies with physiological status

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides.

Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer.

P304

230-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.48.2.230

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

David Cunningham

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274427950

http://www.w3.org/2001/XMLSchema#string

P698

11156646

http://www.w3.org/2001/XMLSchema#string

P921

P932

1728205

http://www.w3.org/2001/XMLSchema#string